MaxCyte Inc
NASDAQ:MXCT

  • LAST PRICE
    4.7400
  • TODAY'S CHANGE (%)
    0.0100 (0.2114%)
  • Bid / Lots
    4.7500/ 1
  • Ask / Lots
    4.7700/ 4
  • Open / Previous Close
    4.7000 / 4.7300
  • Day Range
    4.6000
    4.7850
  • 52 Week Range
    2.4500
    5.5450
  • Volume
    358,721

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 8, 2024

  • May 7, 2024

      Show headlines and story abstract

    • 4:28PM ET on Tuesday May 07, 2024 by MT Newswires
      Companies Mentioned: MXCT
      04:28 PM EDT, 05/07/2024 (MT Newswires) -- ...

    • 4:06PM ET on Tuesday May 07, 2024 by Dow Jones

      (in thousands)
      Three months ended March 31, 2024 2023 ------------------- ----------------- Cash flows from operating activities: Net loss $ (9,526) $ (10,882) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 1,111 962 Non-cash lease expense 116 96 Net book value of consigned equipment sold 11 17 Stock-based compensation 3,015 3,277 Recoveries of bad debt 130 -- Amortization of discounts on investments (1,983) (1,730) Changes in operating assets and liabilities: Accounts receivable (343) 3,399 Accounts receivable -- TIA* -- 916 Inventory 169 (1,706) Prepaid expense and other current assets 689 509 Other assets 33 410 Accounts payable, accrued expenses and other (3,286) 1,227 Operating lease liability (103) 157 Deferred revenue (593) (963) Other liabilities (4) (13) ----------- ---------- Net cash used in operating activities (10,564) (4,324) ----------- ---------- Cash flows from investing activities: Purchases of investments (48,042) (57,814) Maturities of investments 34,450 89,000 Purchases of property and equipment (804) (1,558) Proceeds from sale of equipment -- 9 ---------- Net cash (used in) provided by investing activities (14,396) 29,637 ----------- ---------- Cash flows from financing activities: Proceeds from exercise of stock options 703 1,456 ----------- ---------- Net cash provided by financing activities 703 1,456 ----------- ---------- Net (decrease) increase in cash and cash equivalents (24,257) 26,769 Cash and cash equivalents, beginning of period 46,506 11,064 ----------- ---------- Cash and cash equivalents, end of period $ 22,249 $ 37,833 =========== ==========

    • 4:06PM ET on Tuesday May 07, 2024 by Dow Jones

      (in thousands)
      Three months ended March 31, 2024 2023 ------------------- ----------------- Cash flows from operating activities: Net loss $ (9,526) $ (10,882) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 1,111 962 Non-cash lease expense 116 96 Net book value of consigned equipment sold 11 17 Stock-based compensation 3,015 3,277 Recoveries of bad debt 130 -- Amortization of discounts on investments (1,983) (1,730) Changes in operating assets and liabilities: Accounts receivable (343) 3,399 Accounts receivable -- TIA* -- 916 Inventory 169 (1,706) Prepaid expense and other current assets 689 509 Other assets 33 410 Accounts payable, accrued expenses and other (3,286) 1,227 Operating lease liability (103) 157 Deferred revenue (593) (963) Other liabilities (4) (13) ----------- ---------- Net cash used in operating activities (10,564) (4,324) ----------- ---------- Cash flows from investing activities: Purchases of investments (48,042) (57,814) Maturities of investments 34,450 89,000 Purchases of property and equipment (804) (1,558) Proceeds from sale of equipment -- 9 ---------- Net cash (used in) provided by investing activities (14,396) 29,637 ----------- ---------- Cash flows from financing activities: Proceeds from exercise of stock options 703 1,456 ----------- ---------- Net cash provided by financing activities 703 1,456 ----------- ---------- Net (decrease) increase in cash and cash equivalents (24,257) 26,769 Cash and cash equivalents, beginning of period 46,506 11,064 ----------- ---------- Cash and cash equivalents, end of period $ 22,249 $ 37,833 =========== ==========

Peers Headlines